DNA

Enzolytics, Inc. and the Bulgarian Academy of Sciences Initiate a Cooperative Program Primarily Focusing on Applied and Strategic Research in Immunology for Cancer and HIV/AIDS Applications

 As well as Diabetes, Multiple Sclerosis and Other Diseases   ALLEN, TX / ACCESSWIRE / July 31, 2024 / Enzolytics, Inc.…

1 year ago

Cancer Research in Space for Life on Earth: Five Projects Selected Through ISS National Lab Solicitation in Partnership With NASA

Inaugural Igniting Innovation research announcement is providing more than $7 million in funding to advance cancer research through space-based R&D…

1 year ago

Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities

BURLINGTON, N.C., and FREMONT, Calif., July 29, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive…

1 year ago

IMUNON Announces 11.1 Month Increase in Overall Survival in Patients with Newly Diagnosed, Advanced Ovarian Cancer Treated with IMNN-001

Phase 2 OVATION 2 Study of IMNN-001 administered with standard-of-care chemotherapy as first-line treatment demonstrates a hazard ratio of 0.74…

1 year ago

Foresight Diagnostics Expands Series B Financing to $73.75 Million to Advance the Foresight CLARITY™ MRD Platform

BOULDER, Colo., July 30, 2024 (GLOBE NEWSWIRE) -- Foresight Diagnostics, Inc. (“Foresight”), a leading diagnostics company specializing in the development…

1 year ago

BioCardia Submits for FDA Approval of Morph® DNA™ Steerable Introducer Product Family

SUNNYVALE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the…

1 year ago

Kanazawa University research: High speed atomic force microscopy studies provide insights into influenza A viral replication

KANAZAWA, Japan, July 29, 2024 /PRNewswire/ -- Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, IMDEA Nanoscience (Madrid, Spain)…

1 year ago

CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit

- This Version Removes the Use of 'Presentation' from the Prior-issued Headline -- Linea™ IVT Platform Delivers All The Benefits…

1 year ago

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit

- Linea™ IVT Platform Delivers All The Benefits of Conventional IVT Without dsRNA Contamination - STONY BROOK, NY / ACCESSWIRE…

1 year ago

Boston University Announces Launch of SEQSTER’s 1-Click Records™ to Aid in Development of Early Alzheimer’s Screening Tool

The system will allow researchers to retrieve a person’s longitudinal health record in seconds. DxA-Funded Researcher and Goodes Prize Winner…

1 year ago